Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals
These findings highlight the urgent need for optimizing MF-related anemia and transfusion management to help mitigate the economic strain on healthcare systems and lessen the time-related and emotional impact on patients and caregivers.
Authors
- Francesca Palandri (ORCID: https://orcid.org/0000-0001-8367-5668)
- Giuseppe Alberto Palumbo (ORCID: https://orcid.org/0000-0002-1010-2946)
- Alessandro Inzoli
- Antonella Barone
- G. D'Elia
- M. Breccia
- Daniela Dordoni
- Elisa Formenti
- Victoria Lucia Rabsiun Aramburu
Institutions
- Policlinico Umberto I (IT)
- University of Catania (IT)
- Istituto di Ematologia di Bologna (IT)
- GlaxoSmithKline (Italy) (IT)
- Tecnologie Avanzate (Italy) (IT)
- Azienda Ospedaliera Ospedale Maggiore (IT)
- Associazione Italiana Arbitri (IT)
- Zanasi & Partners (Italy) (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-07
- DOI
- https://doi.org/10.3389/fonc.2025.1549023
- Citations
- 1
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63